Filing Details
- Accession Number:
- 0001192482-12-000232
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-10-17 16:07:03
- Reporting Period:
- 2012-10-15
- Filing Date:
- 2012-10-17
- Accepted Time:
- 2012-10-17 16:07:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1375200 | Nupathe Inc. | PATH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1302567 | P L Ventures Bioadvance | 2929 Arch Street Philadelphia PA 19104 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-10-15 | 113,000 | $3.37 | 378,879 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-10-16 | 72,407 | $3.29 | 306,472 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-10-17 | 37,593 | $3.39 | 268,879 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the weighted average purchase price for price increments ranging from $3.30 to $3.46.
- Represents the weighted average purchase price for price increments ranging from $3.25 to $3.40.
- Represents the weighted average purchase price for price increments ranging from $3.30 to $3.44
- The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price for all transactions reported on this Form 4.
Billionaire Hedge Funds
